Finox Biotech is committed to developing medicines to improve the lives of patients, nurses and IVF specialists. We intend to build a complete portfolio for reproductive medicine and to become the pharmaceutical partner of choice in fertility treatments. Our team provides global support with regard to drug development, regulatory approval, post-approval and life-cycle management.
One of the key steps in this process is clinical development, where volunteers or patients receive a therapy and are observed for the results.
Finox Biotech’s fully integrated Clinical Development operations cover early-stage to full clinical development management of the organisation’s clinical programs.
In addition our Medical Affairs Organisation is focused on developing scientific and medical knowledge and manages our Phase IIIb and Phase IV.